PHARMACOKINETICS AND SAFETY OF A NOVEL CFTR CORRECTOR MOLECULE GLPG2222 IN HEALTHY SUBJECTS AND IN SUBJECTS WITH CYSTIC FIBROSIS: RESULTS FROM TWO PHASE I STUDIES
O. Van de Steen,C. Gesson,K. Conrath,D. Kanters,C. De Boeck,S. Corveleyn,D. Geller,Kock H. De
